THE IMPACT OF FC GAMMA RECEPTOR IIA AND IIIA GENE POLYMORPHISMS ON THE THERAPEUTIC RESPONSE OF RITUXIMAB IN EGYPTIAN ADULT IMMUNE THROMBOCYTOPENIC PURPURA

被引：0
|
作者：
Ellithy, H. [1 ]
Hassan, S. [2 ]
Shaheen, G. [3 ]
Mattar, M. [1 ]
机构：
[1] Cairo Univ, Kasr Al Ainy Sch Med, Internal Med Hematol Subdiv, Cairo, Egypt
[2] Cairo Univ, Kasr Al Ainy Sch Med, Internal Med, Cairo, Egypt
[3] Cairo Univ, Kasr Al Ainy Sch Med, Clin Pathol, Cairo, Egypt
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB2113
引用
收藏
页码：838 / 838
页数：1
相关论文
共 31 条
  • [21] The association of lymphoid protein tyrosine phosphatase non-receptor 22 (PTPN22) gene polymorphism with Egyptian immune thrombocytopenic purpura
    Elhoseiny S.M.
    Morgan D.S.
    Elhadidy K.E.-S.
    Comparative Clinical Pathology, 2013, 22 (3) : 395 - 402
  • [22] Polymorphisms in Fc gamma RIIIa (CD16) receptor expression are associated with clinical response to rituximab in Waldenstrom's macroglobulinemia.
    Treon, SP
    Fox, EA
    Hansen, M
    Verselis, S
    Branagan, A
    Touroutoglou, N
    Maloney, DG
    Frankel, SR
    Anderson, KC
    Emmanouilides, C
    Kimby, E
    BLOOD, 2002, 100 (11) : 573A - 573A
  • [23] Fc-gamma receptor IIA and IIIA variants in two African cohorts: Lack of consistent impact on heterosexual HIV acquisition, viral control, and disease progression
    Connolly, Sarah
    Wall, Kristin M.
    Tang, Jianming
    Yu, Tianwei
    Kilembe, William
    Kijak, Gustavo
    Allen, Susan
    Hunter, Eric
    VIROLOGY, 2018, 525 : 132 - 142
  • [24] Impact of Fc-gamma receptor IIIA polymorphism on late-onset neutropenia and clinical outcomes in kidney transplant recipients following rituximab induction therapy
    Tashiro, Yuki
    Hyodo, Yoji
    Kitamura, Satoshi
    Fujimoto, Takuya
    Endo, Takahito
    Nishioka, Shun
    Yokoyama, Naoki
    Hara, Takuto
    Chiba, Koji
    Miyake, Hideaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2025,
  • [25] Lack of Impact of Cytotoxic T-Lymphocyte Antigen 4 Gene Exon 1 Polymorphism on Susceptibility to or Clinical Course of Egyptian Childhood Immune Thrombocytopenic Purpura
    Radwan, Eman Roshdy
    Goda, Rania L. M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (04) : 378 - 382
  • [26] Impact of CD40 gene variants [(rs1883832) and (rs4810485)] on the risk of immune thrombocytopenic purpura in Egyptian paediatric patients: a case-control study
    Abd El Dayem, Omnia Y.
    Abdullah Aboukhalil, Reham E. E.
    Elhady, Marwa Abd
    Masoud, Mohamed
    Abou-Elalla, Amany A.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2024, 49 (01): : 10 - 21
  • [27] Interleukin-1 Receptor Antagonist Gene Polymorphisms in Egyptian Children and Adolescents With Primary Immune Thrombocytopenia: Association With Disease Susceptibility, Response to Therapy, and Outcome
    Al-Tawil, Mohammed M.
    Kamal, Tarek M.
    Borham, Omnia M.
    El-Ghany, Shereen Abd M.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (05) : E650 - E654
  • [28] Rituximab responsive immune thrombocytopenic purpura in an adult with underlying autoimmune lymphoproliferative syndrome due to a splice-site mutation (IVS7+2 T>C) affecting the Fas gene
    Wei, Andrew
    Cowie, Tiffany
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (04) : 363 - 366
  • [29] C-leptin type receptor 5 and IFN-gamma gene expression and polymorphisms as markers for 17DD Yellow Fever vaccine immune response
    Azamor, T.
    Silva, A. M. V.
    Carvalho, C. X.
    Alvarado-Arnez, L.
    Melgaco, J. G.
    Bayma, C.
    Ano Bom, A. D.
    Moraes, M. O.
    Neves, P. C. C.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 987 - 988
  • [30] The impact of low affinity immunoglobulin gamma Fc region receptor III-A gene polymorphisms in neuromyelitis optica spectrum disorder and implications for treatment outcomes: results from the N-MOmentum study
    Bennett, J. L.
    Weinshenker, B. G.
    Paul, F.
    Kim, H-J
    Aktas, O.
    Hartung, H-P
    Drappa, J.
    Smith, M.
    Rees, W. A.
    She, D.
    Katz, E.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 152 - 153
1234